16 Podcast Episodes
John B. Buse, MD, PhD - Scoring Comprehensive T2DM Management Goals: Examining the Multifaceted Effects of GLP-1 Receptor Agonists
John B. Buse, MD, PhD - Scoring Comprehensive T2DM Management Goals: Examining the Multifaceted Effects of GLP-1 Receptor Agonists
Go online to PeerView.com/ZKJ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
6 Jul 2023
•
1hr 4mins
John B. Buse, MD, PhD - Scoring Comprehensive T2DM Management Goals: Examining the Multifaceted Effects of GLP-1 Receptor Agonists
John B. Buse, MD, PhD - Scoring Comprehensive T2DM Management Goals: Examining the Multifaceted Effects of GLP-1 Receptor Agonists
Go online to PeerView.com/ZKJ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
6 Jul 2023
•
1hr 4mins
John B. Buse, MD, PhD - Scoring Comprehensive T2DM Management Goals: Examining the Multifaceted Effects of GLP-1 Receptor Agonists
John B. Buse, MD, PhD - Scoring Comprehensive T2DM Management Goals: Examining the Multifaceted Effects of GLP-1 Receptor Agonists
Go online to PeerView.com/ZKJ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
6 Jul 2023
•
1hr 4mins
John B. Buse, MD, PhD - Scoring Comprehensive T2DM Management Goals: Examining the Multifaceted Effects of GLP-1 Receptor Agonists
John B. Buse, MD, PhD - Scoring Comprehensive T2DM Management Goals: Examining the Multifaceted Effects of GLP-1 Receptor Agonists
Go online to PeerView.com/ZKJ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
6 Jul 2023
•
1hr 4mins
John B. Buse, MD, PhD - Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
John B. Buse, MD, PhD - Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
Go online to PeerView.com/AZF860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Apr 2022
•
32mins
John B. Buse, MD, PhD - Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
John B. Buse, MD, PhD - Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
Go online to PeerView.com/AZF860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Apr 2022
•
32mins
John B. Buse, MD, PhD - Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
John B. Buse, MD, PhD - Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
Go online to PeerView.com/AZF860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Apr 2022
•
32mins
John B. Buse, MD, PhD - Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases
John B. Buse, MD, PhD - Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases
Go online to PeerView.com/KYQ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
18 Sep 2020
•
1hr 16mins
John B. Buse, MD, PhD - Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases
John B. Buse, MD, PhD - Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases
Go online to PeerView.com/KYQ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
18 Sep 2020
•
1hr 16mins
John B. Buse, MD, PhD - Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases
John B. Buse, MD, PhD - Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases
Go online to PeerView.com/KYQ860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
18 Sep 2020
•
1hr 16mins